Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

M.D. ANDERSON CANCER CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients

Not Applicable

Completed

Conditions: Lymphoma

Interventions: Drug: Cyclophosphamide
Drug: Aprepitant
Drug: Vincristine
Drug: Doxorubicin
Drug: Prednisone
Drug: Rituximab
Drug: Ondansetron

First Posted Date: 2008-04-03

Last Posted Date: 2013-07-02

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 23

Registration Number: NCT00651755

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Relationship Between Quality of Life, Treatment Modalities, and Patient Treatment/Outcome Expectations

Active, not recruiting

Conditions: Rectal Cancer

Interventions: Behavioral: Questionnaire

First Posted Date: 2008-04-01

Last Posted Date: 2025-02-17

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 116

Registration Number: NCT00648635

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Axillary Reverse Mapping for Invasive Carcinoma of the Breast

Phase 1

Completed

Conditions: Breast Cancer

Interventions: Procedure: Axillary Reverse Mapping

First Posted Date: 2008-03-27

Last Posted Date: 2012-08-02

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 35

Registration Number: NCT00645541

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Asian Youth and Tobacco Control Survey

Completed

Conditions: Tobacco Use
Smoking

Interventions: Behavioral: Questionnaire

First Posted Date: 2008-03-25

Last Posted Date: 2012-08-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 617

Registration Number: NCT00642317

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer

Phase 2

Terminated

Conditions: Pancreatic Cancer

Interventions: Drug: RAD001
Drug: Erlotinib

First Posted Date: 2008-03-21

Last Posted Date: 2025-05-01

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 16

Registration Number: NCT00640978

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

Femara (Letrozole) Versus Placebo for Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2

Withdrawn

Conditions: Peritoneal Cancer
Fallopian Tube Cancer
Ovarian Cancer

Interventions: Drug: Placebo
Drug: Femara

First Posted Date: 2008-03-13

Last Posted Date: 2016-04-20

Lead Sponsor: M.D. Anderson Cancer Center

Registration Number: NCT00634894

Locations: 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States

Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain

Phase 3

Terminated

Conditions: Advanced Cancer
Solid Tumors

Interventions: Drug: Methadone
Drug: Morphine

First Posted Date: 2008-03-12

Last Posted Date: 2016-05-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 36

Registration Number: NCT00634010

Locations: 🇺🇸
LBJ General Hospital, Houston, Texas, United States
🇺🇸
The Michael E. DeBakey V.A. Medical Center, Houston, Texas, United States
🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Lifestyle Intervention for Heart Failure

Not Applicable

Active, not recruiting

Conditions: Heart Failure

Interventions: Other: Usual Care
Behavioral: Exercise Training
Behavioral: Dietary Counseling

First Posted Date: 2008-03-12

Last Posted Date: 2025-01-09

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 85

Registration Number: NCT00633633

Locations: 🇺🇸
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Spirituality/Religiosity in Patients and Caregivers

Completed

Conditions: Advanced Cancer
Solid Tumors

Interventions: Behavioral: Questionnaires

First Posted Date: 2008-03-12

Last Posted Date: 2023-03-27

Lead Sponsor: M.D. Anderson Cancer Center

Target Recruit Count: 193

Registration Number: NCT00634257

Locations: 🇺🇸
University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Intraoperative Optical Imaging of Brain Function

Withdrawn

Conditions: Brain Tumor

Interventions: Procedure: Speckle-Contrast Imaging

First Posted Date: 2008-03-10

Last Posted Date: 2012-07-30

Lead Sponsor: M.D. Anderson Cancer Center

Registration Number: NCT00632437

Locations: 🇺🇸
U.T.M.D. Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy